{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:28:47Z","timestamp":1792801727658,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ymgme.2011.04.018","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T00:22:02Z","timestamp":1304986922000},"page":"383-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations"],"prefix":"10.1016","volume":"103","author":[{"given":"Christian P.","family":"Schaaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Blazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Alan","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross E.","family":"Tonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Jun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Scaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2011.04.018_bb0005","doi-asserted-by":"crossref","unstructured":"P. Yu-Wai-Man, P.G. Griffiths, A. Burke, P.W. Sellar, M.P. Clarke, L. Gnanaraj, D. Ah-Kine, G. Hudson, B. Czermin, R.W. Taylor, R. Horvath, P.F. Chinnery, The prevalence and natural history of dominant optic atrophy due to OPA1 mutations Ophthalmology 117 (2010) 1538\u20131546, 1546.e1.","DOI":"10.1016\/j.ophtha.2009.12.038"},{"key":"10.1016\/j.ymgme.2011.04.018_bb0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.116.3.351","article-title":"Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy","volume":"116","author":"Votruba","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurological disease is common in patients with OPA1 mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.04.018_bb0020","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/hmg\/10.13.1359","article-title":"OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance","volume":"10","author":"Pesch","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0025","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1373\/clinchem.2009.141549","article-title":"Quantitative evaluation of the mitochondrial DNA depletion syndrome","volume":"56","author":"Dimmock","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0030","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.nmd.2008.05.009","article-title":"Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations","volume":"18","author":"Milone","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.mito.2009.03.001","article-title":"Mitochondrial disorder with OPA1 mutation lacking optic atrophy","volume":"9","author":"Milone","year":"2009","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2011.04.018_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1399-0004.2005.00499.x","article-title":"Relationship of primary mitochondrial respiratory chain dysfunction to fiber type abnormalities in skeletal muscle","volume":"68","author":"Enns","year":"2005","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0045","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1212\/WNL.51.4.1190","article-title":"Mitochondrial DNA depletion in a patient with long survival","volume":"51","author":"Vu","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2011.04.018_bb0050","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/hep.21799","article-title":"Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy","volume":"46","author":"Wong","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2011.04.018_bb0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/humu.20607","article-title":"Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons","volume":"29","author":"Schimpf","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0065","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/archneurol.2009.139","article-title":"Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B","volume":"66","author":"Shaibani","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0070","first-page":"1715","article-title":"A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy","volume":"43","author":"Thiselton","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0075","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/hmg\/10.13.1369","article-title":"Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy","volume":"10","author":"Toomes","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0080","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/brain\/awm005","article-title":"A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy","volume":"130","author":"Alavi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.04.018_bb0085","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/ddm079","article-title":"Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function","volume":"16","author":"Davies","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awm298","article-title":"OPA1 mutations induce mitochondrial DNA instability and optic atrophy \u2018plus\u2019 phenotypes","volume":"131","author":"Amati-Bonneau","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.04.018_bb0095","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1093\/hmg\/ddq209","article-title":"OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules","volume":"19","author":"Yu-Wai-Man","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0100","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1093\/hmg\/ddn225","article-title":"A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function","volume":"17","author":"Spinazzi","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2091-9-22","article-title":"Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy","volume":"9","author":"Mayorov","year":"2008","journal-title":"BMC Biochem."},{"key":"10.1016\/j.ymgme.2011.04.018_bb0110","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1167\/iovs.09-3634","article-title":"Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy","volume":"50","author":"Yu-Wai-Man","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719211001351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719211001351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:19:59Z","timestamp":1761088799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719211001351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1096719211001351"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2011.04.018","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2011.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}